Found 10 results

↓ CSV
Name Type of Offering Accepted Date
RXi Pharmaceuticals Corp
D 2017-08-18 17:17:34
Amount To Be Raised $15,261,000
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001209191-17-049646
Exclusions or Exemptions 506b
Accepted Date 2017-08-18 17:17:34
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Phio Pharmaceuticals Corp.
D 2020-04-14 17:16:30
Amount To Be Raised $4,375,011
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001683168-20-001189
Exclusions or Exemptions 506b
Accepted Date 2020-04-14 17:16:30
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
Phio Pharmaceuticals Corp.
D 2023-05-02 16:15:08
Amount To Be Raised $4,010,519
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001683168-23-002852
Exclusions or Exemptions 506b
Accepted Date 2023-05-02 16:15:08
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets No Revenues
Type of Security Option To Acquire
Phio Pharmaceuticals Corp.
D 2021-02-12 17:42:26
Amount To Be Raised $24,264,137
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001683168-21-000554
Exclusions or Exemptions 506b
Accepted Date 2021-02-12 17:42:26
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Phio Pharmaceuticals Corp.
D 2022-11-23 16:00:37
Amount To Be Raised $1,750
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001567619-22-020839
Exclusions or Exemptions 506b
Accepted Date 2022-11-23 16:00:37
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets No Revenues
Type of Security Equity
Phio Pharmaceuticals Corp.
D 2023-12-19 13:07:40
Amount To Be Raised $5,399,124
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001123292-23-000208
Exclusions or Exemptions 506b
Accepted Date 2023-12-19 13:07:40
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets No Revenues
Type of Security Option To Acquire
RXi Pharmaceuticals Corp
D 2013-03-26
Amount To Be Raised $23,628,750
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001551333-13-000051
Exclusions or Exemptions N/A
Accepted Date 2013-03-26
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Phio Pharmaceuticals Corp.
D 2020-02-24 17:27:13
Amount To Be Raised $1,903,128
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001683168-20-000567
Exclusions or Exemptions 506b
Accepted Date 2020-02-24 17:27:13
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
RXi Pharmaceuticals Corp
D/A 2018-08-17 17:00:31
Amount To Be Raised $15,261,000
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001683168-18-002407
Exclusions or Exemptions 506b
Accepted Date 2018-08-17 17:00:31
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Phio Pharmaceuticals Corp.
D 2023-06-13 16:40:32
Amount To Be Raised $10,907,728
Associated Brokers / Dealers N/A
CIK Number 0001533040
Filed Document 0001683168-23-004102
Exclusions or Exemptions 506b
Accepted Date 2023-06-13 16:40:32
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets No Revenues
Type of Security Equity